Phase II trial of patupilone in patients with brain metastases from breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Brain Neoplasms
  • Breast Neoplasms
  • Epothilones

abstract

  • Patupilone in patients with BCBM did not meet the efficacy criteria and had significant gastrointestinal toxicity. Further study of brain-penetrant agents is warranted for patients with CNS metastases from breast cancer.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3956359

Digital Object Identifier (DOI)

  • 10.1093/neuonc/not305

PubMed ID

  • 24470546

Additional Document Info

start page

  • 579

end page

  • 83

volume

  • 16

number

  • 4